TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/8/23 19:00 | 6/6/23 | SANA | Sana Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund V General Partner LLC | MA | T | S.m | -2,533 | 6.27 | 0 | -404 | -1 | 33,290 | I | |||||||||||||||
5/26/23 20:00 | 5/24/23 | SANA | Sana Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund V General Partner LLC | MA | T | S.m | -3,527 | 6.47 | 0 | -545 | -2 | 33,694 | I | |||||||||||||||
9/16/22 19:30 | 9/15/22 | CDAK | Codiak Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund V General Partner LLC | MA | T | P.d | 0 | 0.00 | 0 | 933 | 36 | 3,541 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |